Hepatic tumor ablation: application in a community hospital setting

Kwan N Lau; Ryan Z Swan; David Sindram; John B Martinie; David A Iannitti

doi:10.1016/j.soc.2011.01.003

Hepatic tumor ablation: application in a community hospital setting

Surg Oncol Clin N Am. 2011 Jul;20(3):455-66, viii. doi: 10.1016/j.soc.2011.01.003.

Authors

Kwan N Lau¹, Ryan Z Swan, David Sindram, John B Martinie, David A Iannitti

Affiliation

¹ Hepato-Pancreato-Biliary Surgery, Department of General Surgery, Carolinas Medical Center, 1025 Morehead Medical Plaza Drive, Suite 300, Charlotte, NC 28204, USA.

PMID: 21640915
DOI: 10.1016/j.soc.2011.01.003

Abstract

Primary liver tumors are a common clinical problem in the United States and worldwide. Resection has historically been used to treat liver lesions. Commonly used liver-directed therapies include transarterial chemoembolization, selective internal radiation therapy, and ablative therapy. Only ablative therapy can cause direct destruction of the targeted tissue. The commercially available modalities in the United States are all based on thermoablative technology. This article examines the various ablative technologies and their application, as well as how these procedures can be performed safely and with optimal outcomes, in a community cancer center.

MeSH terms

Cancer Care Facilities*
Carcinoma, Neuroendocrine / pathology
Carcinoma, Neuroendocrine / therapy*
Catheter Ablation*
Colorectal Neoplasms / pathology
Colorectal Neoplasms / therapy*
Combined Modality Therapy
Embolization, Therapeutic*
Hospitals, Community*
Humans
Liver Neoplasms / secondary
Liver Neoplasms / therapy*
United States